All establishments licensed to carry out activities under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 must submit data relating to the activities undertaken and the tissue types worked with between 1 January and 31 December on an annual basis.
Submission of the data is a condition of your HTA licence.
Earlier this year the Minister for Innovation laid out a challenge to health regulators, the Professional Standards Authority, NICE and NHSX during an unprecedented roundtable. If the post-Brexit ambition, as outlined in the government’s Life Sciences Vision, is to provide a world-class regulatory environment that benefits patients and the public while also promoting jobs, growth, and investment, how do we collectively
Clinicians and transplant teams are responsible for the overall care of donors and recipients, and for assessing the medical suitability of potential donors. The Regulations require the clinician with responsibility for the donor to refer the matter to the HTA. As part of this referral specific information, certain assurances are required to ensure the legislative requirements are addressed.
Our Chief Executive Allan Marriott-Smith takes a look back over the last decade of the HTA.
I’m sure I’m not alone in the thinking that coming to the end of another decade has relatively few highlights. I can say for certain that in January 2020 I’m older, greyer and wrinklier than in 2010, and my knees have seen better days.
On December 1 2015, Wales became the first country in the UK to implement a ‘soft opt-out’ system for organ donation. Earlier this year we learnt that this has significantly increased consent rates for deceased donation when compared with England. At the time of the law change consent rates in Wales were the lowest in the UK (less than 50%). Now they are the highest by some distance (77% compared with 67% for the rest of the UK).
